Breast Imaging: Page 31

Hybrid imaging proves value in staging of breast cancer

By Will Morton

PET/CT is very useful in detecting axillary metastases in breast cancer patients and provides important information about the extent of axillary and extra-axillary lymph node involvement, according to researchers from Tel Aviv University.

April 8, 2021

Swedish study underlines potential value of digital breast tomosynthesis

By Amerigo Allegretto

Researchers from Sweden have reported that the use of digital breast tomosynthesis may result in lower interval cancer rates and earlier detection than the use of conventional digital mammography.

April 7, 2021

Micrima raises over 4.5M euros in new financing round

By AuntMinnieEurope.com staff writers

U.K.-based breast imaging technology developer Micrima said it has raised 3.8 million pounds (4.5 million euros) in a new financing round.

March 29, 2021

EUSOBI unveils plan to support young researchers

By AuntMinnieEurope.com staff writers

The European Society of Breast Imaging (EUSOBI) has announced that it will award three grants in 2021 to support young researchers interested in developing projects in the field of breast imaging.

March 25, 2021

Koios Medical's AI for detecting breast cancer gets CE Mark

By AuntMinnieEurope.com staff writers

Koios Medical has received the CE Mark for its Koios DS Breast Smart Ultrasound decision-support software for interpreting breast ultrasound images.

March 17, 2021

Debate grows over AI replacing second reader in mammography

By Erik L. Ridley

Can artificial intelligence (AI) software replace the second reader used in many breast cancer screening programs in Europe? Dr. Sylvia Heywang-Köbrunner and other experts addressed this hot topic at ECR 2021.

March 16, 2021

Estrogen receptor tied to outcomes in DCIS

By AuntMinnieEurope.com staff writers

The estrogen receptor (ER) plays a key role in predicting long-term outcomes in patients with ductal carcinoma in situ (DCIS), researchers from Queen Mary University of London reported in a study published online on 16 March in Clinical Cancer Research.

March 15, 2021

Magnetic seeds enhance breast care at London's Royal Free

By Philip Ward

Magnetic seeds are a feasible, cost-effective, and safe method of localizing breast lesions, and they're proving popular with both patients and breast surgeons, according to new research from the Royal Free London NHS Foundation Trust.

March 9, 2021

Kuhl provides master class on breast MRI at ECR 2021

By Frances Rylands-Monk

Not everything that glitters is gold, and not everything that enhances in breast MRI is due to breast cancer. That was one of the core messages of Prof. Dr. Christiane Kuhl, PhD, chair of radiology at Aachen University Hospital in Germany, in her ECR talk on how to identify malignant lesions on MRI.

March 8, 2021

AI enhances classification of breast density on mammography

By Erik L. Ridley

An artificial intelligence (AI)-based software application can reduce inter-reader variability in breast density classifications, enabling more consistent mammography reports, according to research presented at ECR 2021.

March 8, 2021

Lancet commission highlights unequal access to imaging

By Emily Hayes

The Lancet Oncology Commission on Medical Imaging and Nuclear Medicine presented its findings from a major research effort on global health disparities on 4 March at ECR 2021. It's vital to get governments to scale up imaging infrastructure, said Dr. Hedvig Hricak, PhD.

March 4, 2021

AI and breast density foretell potential risk of interval cancer

By Erik L. Ridley

The combination of breast density and artificial intelligence (AI)-based analysis may be able to significantly reduce the number of interval cancers missed in mammography screening programs, Dutch researchers reported in a Thursday presentation at ECR 2021.

March 4, 2021

Previous Page

Page 31 of 142

Next Page